We are live on
!
Find out more
CC
Centiva Capital Portfolio holdings
AUM
$2.15B
1-Year Est. Return
20%
This Fund
S&P 500
This Quarter
Est. Return
+6.42%
1 Year Est. Return
+20%
3 Year Est. Return
+47.47%
5 Year Est. Return
+70.97%
10 Year Est. Return
–
AUM
$1.8B
AUM Growth
+$600M
(+50%)
Cap. Flow
+$340M
Cap. Flow
% of AUM
18.85%
Top 10 Holdings %
Top 10 Hldgs %
18.21%
Holding
1,541
New
572
Increased
220
Reduced
141
Closed
422
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$60.7M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$44.5M |
| 3 |
Brookfield
BN
|
+$38.3M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$37.9M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$30.2M |
Top Sells
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$19.1M |
| 2 |
FPAC
Far Peak Acquisition Corporation
FPAC
|
+$14.8M |
| 3 |
DRAY
Macondray Capital Acquisition Corp. I Class A Ordinary Shares
DRAY
|
+$14.4M |
| 4 |
Apple
AAPL
|
+$13.5M |
| 5 |
Tesla
TSLA
|
+$11.1M |
Sector Composition
| 1 | Financials | 28.88% |
| 2 | Industrials | 9.45% |
| 3 | Technology | 8.63% |
| 4 | Healthcare | 6.48% |
| 5 | Consumer Discretionary | 5.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
BioMarin Pharmaceuticals
BMRN
$11.4B
| $203K | 0.01% |
2,090
-20,985
| -91% | -$2.18M |
|
827
Polaris
PII
$3.83B
| $203K | 0.01% |
1,835
-208
| -10% | -$23K |
|
828
Fresenius Medical Care
FMS
$12.9B
| $203K | 0.01% |
+9,540
| New | +$183K |
|
829
Westamerica Bancorp
WABC
$1.37B
| $203K | 0.01% |
4,578
+32
| +0.7% | +$1.72K |
|
830
Central Garden & Pet Co Class A
CENTA
$2.35B
| $203K | 0.01% |
+6,483
| New | +$199K |
|
831
Alamo Group
ALG
$1.96B
| $203K | 0.01% |
+1,100
| New | +$181K |
|
|
ITCI
832
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $202K | 0.01% |
+3,735
| New | +$181K |
|
833
Ocugen
OCGN
$498M
| $202K | 0.01% |
+237,500
| New | +$259K |
|
834
GXO Logistics
GXO
$5.82B
| $202K | 0.01% |
3,994
-6,613
| -62% | -$329K |
|
835
Amphastar Pharmaceuticals
AMPH
$825M
| $200K | 0.01% |
+5,344
| New | +$175K |
|
836
lululemon athletica
LULU
$13.5B
| $200K | 0.01% |
550
-2,982
| -84% | -$935K |
|
837
Royal Caribbean
RCL
$76.5B
| $199K | 0.01% |
3,048
-38,980
| -93% | -$2.57M |
|
838
Smith & Wesson
SWBI
$698M
| $198K | 0.01% |
+16,083
| New | +$172K |
|
|
ROIC
839
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $197K | 0.01% |
+14,137
| New | +$205K |
|
840
BridgeBio Pharma
BBIO
$16.8B
| $197K | 0.01% |
+11,900
| New | +$139K |
|
841
Yext
YEXT
$510M
| $193K | 0.01% |
+20,108
| New | +$155K |
|
842
Global Ship Lease
GSL
$1.44B
| $193K | 0.01% |
+10,276
| New | +$192K |
|
|
ROCL
843
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
| $190K | 0.01% |
18,377
| – | – |
|
|
ELME
844
Elme Communities
ELME
$135M
| $189K | 0.01% |
+10,600
| New | +$194K |
|
845
Urban Edge Properties
UE
$2.87B
| $188K | 0.01% |
+12,460
| New | +$188K |
|
|
FRLA
846
DELISTED
Fortune Rise Acquisition Corporation Class A Common Stock
FRLA
| $184K | 0.01% |
17,281
| – | – |
|
847
ICL Group
ICL
$6.26B
| $184K | 0.01% |
27,014
+12,095
| +81% | +$89.3K |
|
848
Uranium Energy
UEC
$5.21B
| $181K | 0.01% |
+63,000
| New | +$228K |
|
|
OPLN
849
Openlane
OPLN
$4.23B
| $180K | 0.01% |
13,189
-1,694
| -11% | -$23.5K |
|
850
UiPath
PATH
$6.05B
| $180K | 0.01% |
10,254
-5,387
| -34% | -$81.4K |
|
Similar funds
PI
GA
SAG
SC
MA
NAAA
CM
DSCM